Protein misfolding‐specific epitope identification for passive and active immunotherapy of neurodegenerative diseases

ProMIS has circumvented the specificity limitations of conventional immunizations to enable selective passive and active immunotherapies for neurodegenerative diseases.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70859_098670
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Protein misfolding‐specific epitope identification for passive and active immunotherapy of neurodegenerative diseases

Ebrima Gibbs, Erin Scruten, Steven S. Plotkin, Johanne Kaplan et al.
Alzheimer s & Dementia
Alzheimer's disease research and treatments
article

Protein misfolding‐specific epitope identification for passive and active immunotherapy of neurodegenerative diseases

Ebrima Gibbs, Erin Scruten, Steven S. Plotkin, Johanne Kaplan, Scott Napper, Beibei Zhao, Neil R Cashman, Juliane Coutts
article en

Abstract

ProMIS has circumvented the specificity limitations of conventional immunizations to enable selective passive and active immunotherapies for neurodegenerative diseases.

Alzheimer s & DementiaVol. 21(S5)
University of British Columbia (CA), University of Saskatchewan (CA), Amorfix (Canada) (CA)
Openalex Percentile: Top 33%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.